IOVA - Iovance Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IOVA is currently covered by 5 analysts with an average price target of $9.27. This is a potential upside of $8.39 (7.79%) from yesterday's end of day stock price of $8.6.

Iovance Biotherapeutics's activity chart (see below) currently has 221 price targets and 200 ratings on display. The stock rating distribution of IOVA is 55.56% BUY and 44.44% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.33% with an average time for these price targets to be met of 137.87 days.

Highest price target for IOVA is $16, Lowest price target is $4, average price target is $9.27.

Most recent stock forecast was given by DAVID DAI from UBS on 20-Aug-2026. First documented stock forecast 04-Aug-2017.

Currently out of the existing stock ratings of IOVA, 5 are a BUY (55.56%), 4 are a HOLD (44.44%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 05-Mar-2026

$7

$-1.6 (-18.60%)

$4

24 days ago
(20-Aug-2026)

1/3 (33.33%)

$-1.99 (-22.14%)

8

Buy Since 20-May-2019

$16

$11.75 (276.47%)

5 months 3 days ago
(10-Apr-2026)

4/18 (22.22%)

$12.3 (332.43%)

131

Hold Since 25-Feb-2026

$5

$0.75 (17.65%)

$5

6 months 10 days ago
(03-Mar-2026)

4/15 (26.67%)

$1.25 (33.33%)

30

Buy Since 24-Nov-2025

$11

$7.49 (213.39%)

$10

6 months 19 days ago
(25-Feb-2026)

0/3 (0%)

$7.17 (187.21%)

Buy Since 04-Mar-2020

$10

$5.75 (135.29%)

$9

8 months 27 days ago
(17-Dec-2025)

3/11 (27.27%)

$7.48 (296.83%)

105

Show more analysts

Please expand the browser size to see the chart

What is IOVA (Iovance Biotherapeutics) average time for price targets to be met?

On average it took 138 days for the stock forecasts to be reached, with an average price target met ratio of 35.33%.

Which analyst most recently updated their price target on IOVA (Iovance Biotherapeutics)?

David Dai

Which analyst has the most public recommendations on IOVA (Iovance Biotherapeutics)?

David Dai works at UBS and has 3 price targets and 2 ratings on IOVA

Which analyst is the currently most bullish on IOVA (Iovance Biotherapeutics)?

Biren Amin with the highest potential upside of $39.3

Which analyst is the currently most reserved on IOVA (Iovance Biotherapeutics)?

Reni Benjamin with the lowest potential downside of -$3.6

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?